Soligenix updates medical advisory board for lymphoma drug development

Go back to Soligenix updates medical advisory board for lymphoma drug development
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.40 --0 (-0%)
Previous Close $0.40    52 Week High $4.35 
Open $0.41    52 Week Low $0.44 
Day High $0.41    P/E N/A 
Day Low $0.40    EPS $-0.81 
Volume 242,984